Riddhi Siddhi Gluco Biols Ltd

On 25-Nov, Riddhi Siddhi Gluco Biols Ltd witnessed a significant decline in its share price, falling by 6.22% to close at ₹487.55. This drop reflects a broader trend of underperformance relative to market benchmarks and sector peers, signalling investor concerns and bearish sentiment surrounding the stock.

Riddhi Siddhi Gl has experienced significant fluctuations in financial performance, with net sales declining from 681.81 Cr in Mar'19 to 135.51 Cr in Mar'25, while profit before tax improved from a loss of 18.09 Cr in Mar'21 to a profit of 71.48 Cr in Mar'25. Despite volatility, recent years show signs of stabilization in profitability.

Riddhi Siddhi Gl has experienced significant fluctuations in financial performance, with net sales declining from 681.81 Cr in Mar'19 to 135.51 Cr in Mar'25, while profit before tax improved from a loss in Mar'21 to a profit in Mar'25. The company has faced challenges, including negative cash flow in Mar'25 and inconsistent net profit.

Riddhi Siddhi Gl will declare its results on 13 November 2025.

As of 20-Oct, Riddhi Siddhi Gluco Biols Ltd's stock price is Rs 538.00, down 3.32%, and has underperformed its sector. The stock has declined significantly year-to-date by 15.80%, contrasting with the Sensex's gain of 7.97%.

As of 25-Sep, Riddhi Siddhi Gluco Biols Ltd is currently priced at Rs 562.00, reflecting a 0.64% increase, but it is trading below all key moving averages, indicating a longer-term downward trend despite recent short-term gains. Investor participation has decreased significantly, suggesting reduced confidence, and the stock has underperformed year-to-date compared to the benchmark Sensex.

Riddhi Siddhi Gl has experienced significant fluctuations in financial performance, with net sales declining from 681.81 Cr in Mar'19 to 135.51 Cr in Mar'25, and inconsistent profitability, including a loss of 84.91 Cr in Mar'23 and a recovery to a profit of 43.87 Cr in Mar'24 before another loss in Mar'25. Total liabilities decreased, but cash flow from operations has been erratic.

As of 13-Aug, Riddhi Siddhi Gluco Biols Ltd's stock price is 540.00, up 4.25%, but it remains below key moving averages, indicating a bearish trend. The company faces significant financial challenges, including operating losses and a negative return on capital, leading to a concerning long-term outlook despite recent short-term gains.

Riddhi Siddhi Gluco Biols reported strong sales growth of 984.22% year-on-year, reaching Rs 154.61 crore, but faced significant declines in profitability, with a profit before tax of Rs -4.48 crore and rising interest costs, indicating challenges ahead despite the positive sales trend.

As of 12-Aug, Riddhi Siddhi Gluco Biols Ltd's stock price is Rs 518.00, down 0.38%, continuing a downward trend with a total return loss of 3.88% over the last two days. The stock has significantly underperformed against the benchmark indices, with a year-to-date decline of 18.93%, despite increased investor participation.

As of 11-Aug, Riddhi Siddhi Gluco Biols Ltd's stock price is Rs 520.00, down 3.51%, with high volatility and significant underperformance compared to the Sensex. Despite increased investor participation, the stock has declined 18.62% year-to-date, indicating a bearish trend.

Riddhi Siddhi Gl will declare its results on 13 August 2025.

As of 08-Aug, Riddhi Siddhi Gluco Biols Ltd is priced at Rs 538.90, having increased by 0.4% today but is on a downward trend with a total decline of 6.11% over the last three days. The stock has underperformed compared to the Sensex, with a year-to-date drop of 15.66%, indicating ongoing challenges despite a slight recovery.

As of 07-Aug, Riddhi Siddhi Gluco Biols Ltd is priced at 536.75, down 0.42%, and has seen a total decline of 5.47% over the last two days. The stock is underperforming the market with a year-to-date return of -15.99%, indicating bearish sentiment and a lack of sustained buying interest.

As of 06-Aug, Riddhi Siddhi Gluco Biols Ltd's stock price is Rs 539.00, down 5.07%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with a year-to-date decline of 15.64%, contrasting sharply with the Sensex's gain of 3.08%.

As of 24th July, Riddhi Siddhi Gluco Biols Ltd has a market capitalization of 438.00 Cr, with net sales of 135.51 Cr and a net profit of 5.20 Cr reported in the latest four quarters. The balance sheet for March 2024 shows shareholder's funds of 1,536.78 Cr and total assets of 1,773.69 Cr.